Processing the protocol with id 168
##########################################
Searching for the item "2a Scientific background and explanation of rationale..."
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Searching for the item "2b Specific objectives or hypotheses"...
This part was defined, probably, at this section: 2 STUDY OBJECTIVES
For more information about the primary objectives, go to sections:
2.1 Primary Objectives 
For more information about the secondary objectives, go to sections:
2.2 The secondary objectives of this study are:
Objectives: FOUND
Occurrences in the text:
36817	compare 	"... s to compare the PFS of the drug combination IMC 1121 B  plus docetaxel to placebo plus docetaxel in..."
37099	compare 	"...   To compare  the overall survival of  the drug combination  IMC 1121 B plus docetaxel to placebo plus..."
37347	compare 	"...   To compare the TTP, ORR, and duration of response between the   To compare the safety of the two..."
37411	compare 	"...   To compare the safety of the two treatment arms  To compare the quality of life of the two treatment..."
37460	compare 	"...   To compare the quality of life of the two treatment arms  To assess the immunogenicity of IMC 1121 B..."
##########################################
Searching for the item "3a Description of trial design (such as parallel, factorial) including allocation ratio"...
Unfortunately, I could not find this part, maybe, due to bad conversion to txt file!
##########################################
Checking for the item "4a Eligibility criteria for participants..."
This part was defined, probably, at this section: 3.4 Patient Enrollment
I have found neither inclusion nor exclusion criteria
##########################################
Checking for the item "5 Interventions for each group with sufficient details to allow replication, including how and when they were actually administered"
This part was defined, probably, at this section: 5 STUDY TREATMENTS
Maybe, these sections will be interested for you:
5.2 Treatment Compliance
5.3 Packaging and Labeling
##########################################
Checking for the item “7a how sample size was determined”...
This part was defined, probably, at this section: 12.2 Determination of Sample Size
##########################################
Searching any information about a randomzation
This part was defined, probably, at this section: 3.6 Randomization
Maybe this information will be interesting:
38045	will be randomized	"...  breast adenocarcinoma that is metastatic or locally recurrent and inoperable with  curative intent will be randomized. Patients may not have received chemotherapy for metastatic or locally..."
38209	will be randomized	"... for metastatic or locally recurrent, inoperable breast cancer. It is anticipated that 1113 patients will be randomized with 371 patients in the docetaxel plus  placebo arm and 742 patients in the..."
189397	will be randomized	"... tistical Analysis Plan. 12.9 Blinding This is a randomized, double blind, Phase III study. Patients will be randomized to receive IMC  1121 B or matching placebo in a double blind fashion such that..."
##########################################
Checking for the item “11a  if done, who was blinded after assignment to interventions (eg, participants, care providers, those assessing outcomes) and how.”
This part was defined, probably, at this section: 12.9 Blinding
This part was defined, probably, at this section: 13.5 Study Monitoring
##########################################
Checking for the item “12a  statistical methods used to compare groups for primary and secondary outcomes”
This part was defined, probably, at this section: 12 PLANNED STATISTICAL METHODS
I found the following methods:
176931 	 log rank 	 "... ssessment. The  comparison will use the log rank test, stratified by prior use..."
177260 	 log rank 	 "... dditional analysis with an unstratified log rank test will also be  performed...."
180703 	 log rank 	 "...  will be  compared using the stratified log rank test and the survival curves..."
182793 	 log rank 	 "... r. Analysis of efficacy will follow the log rank test and survival curves..."
185735 	 log rank 	 "... day of their last tumor assessment. The log rank test will be performed to ..."
177431 	  cox  	 "... e Kaplan Meier methodology. A stratified Cox proportional hazards regression..."
177638 	  cox  	 "... hazard ratio. An additional unstratified Cox regression model will be  employed..."
183400 	 cochran mantel haenszel 	 "... atment group will be compared using the Cochran Mantel Haenszel test adjusting..."
177393 	 kaplan meier 	 "... ent groups will be generated  using the Kaplan Meier methodology. A stratified..."
180883 	 kaplan meier 	 "... ment group will be  generated using the Kaplan Meier methodology. One single..."
